Product Benefits

• Effective Intraocular Pressure (IOP) Reduction: Benozol PF actively lowers high pressure within the eye, a critical step in managing open-angle glaucoma and ocular hypertension.

• Glaucoma Management: By reducing IOP, it helps mitigate the risk of optic nerve damage and subsequent progressive visual field loss associated with glaucoma.

• Carbonic Anhydrase Inhibition: The active ingredient, Brinzolamide, works as a carbonic anhydrase inhibitor to decrease the production of aqueous humor (the fluid in the eye), thereby reducing pressure.

• Preservative-Free Formulation (PF): The "PF" designation indicates it is preservative-free, which is beneficial for patients who may be sensitive, irritated, or allergic to common preservatives found in standard eye drops, offering increased comfort and better tolerability for long-term use.

• Monotherapy or Adjunctive Use: It can be used alone (monotherapy) or in combination with other topical ophthalmic drugs (like beta-blockers) to achieve the target intraocular pressure.

• Easy Administration: Typically administered as one drop in the affected eye(s) multiple times daily (e.g., three times daily), though dosage should be strictly followed as prescribed by a doctor.

Note: Benozol PF is a prescription medication. Please consult a qualified healthcare professional, such as an ophthalmologist, for diagnosis and appropriate usage instructions.